IDXX MEXC RealStocks
Own real IDXX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-14 15:20:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Idexx Laboratories Inc. (IDXX) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $704.42, with a market capitalization of $54.99B and a P/E ratio of 46.52. Over the past 52 weeks, its price has ranged from $500.61 to $769.98. This page covers its latest market performance, valuation, price trends and company information.
$54.99B | |
$710.24 | |
$710.68 | |
$695.94 | |
$698.02 | |
280.02K | |
565.97K | |
46.52 | |
$769.98 | |
$500.61 | |
-- | |
12-31 |
Idexx Laboratories Inc. (IDXX) last closed at $704.42 as of 2026-11-14 00:31:00, up 0.92% ($6.44) from the previous close of $698.02.
During the latest regular trading session, IDXX traded between $695.94 and $710.68, with a volume of 280.02K shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, Idexx Laboratories Inc. (IDXX) moved from $670.71 to $704.42, representing a gain of 5.03% ($33.71).
The stock traded between $650.00 and $712.88 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 561.93 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 75.7%
IDXX is currently trading at $704.42, placing it 75.7% of the way from its 52-week low of $500.61 to its 52-week high of $769.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Employees | 11,000 |
| CEO | Michael G. Erickson |
| Founded | 1983 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Idexx Laboratories Inc. (IDXX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to IDXX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between IDXX shares and USD.
IDXX Shares to USD
1.00 IDXX shares = 704.418 USD
Calculations are estimates based on the latest available price and are for reference only.